Home/Filings/4/0001104659-24-098692
4//SEC Filing

Fain Eric S 4

Accession 0001104659-24-098692

CIK 0001814114other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 7:43 PM ET

Size

10.1 KB

Accession

0001104659-24-098692

Insider Transaction Report

Form 4
Period: 2024-09-06
Fain Eric S
Director
Transactions
  • Sale

    Common Stock

    2024-09-10$5.34/sh1,800$9,61241,210 total(indirect: By Trust)
  • Sale

    Common Stock, par value $0.0001 per share ("Common Stock")

    2024-09-06$5.64/sh2,000$11,28044,810 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-09-09$5.43/sh1,800$9,77443,010 total(indirect: By Trust)
Footnotes (4)
  • [F1]The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
  • [F2]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.54 to $5.78, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.53, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.14 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

Entity typeother

Related Parties

1
  • filerCIK 0001402222

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 7:43 PM ET
Size
10.1 KB